Clinical Trial Update: Effect of the InsuPatch on Automated Closed-loop Glucose Control in Type 1 Diabetes [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial results evaluate the InsuPatch device for improving automated closed-loop glucose control in individuals with Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• InsuPatch

Snippet

Sponsor: Yale University | Conditions: Type 1 Diabetes | EARLY_Phase 1 | Status: COMPLETED